More than 40 agreements, initiatives and announcements with an estimated combined value above SAR5 billion came out of the fourth Riyadh Global Medical Biotechnology Summit 2026, which ended yesterday. They cover partnerships, programs and projects designed to localize biotechnology and strengthen its health and economic impact.

Experts and delegations from over 57 countries attended, along with more than 200 speakers, while visitors and registrants topped 15,000. The program ran to over 80 sessions plus seven high-level executive sessions on artificial intelligence, genomics, vaccines, biomanufacturing, advanced therapies, investment and talent development.

At the Life Sciences Innovation Forum, five specialist investment funds said they were ready to invest more than $120 million in promising opportunities and companies. The Next Generation Biotechnologist Forum concentrated on supporting researchers and scientists early in their careers.

The exhibition covered more than 6,000 square meters, with over 120 sponsors and exhibitors and international pavilions from Spain, China, Japan, Germany, the United States and the Republic of Korea.